Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Chan-Young Jung, Jai Won Chang

Clin Mol Hepatol. 2023;29(4):891-908. Published online April 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0024

View: 7290 Download: 1,270 Web of Science: 5 Crossref: 6

Han Ah Lee, Yeon Seok Seo

Clin Mol Hepatol. 2022;28(1):31-46. Published online August 2, 2021

DOI: https://doi.org/10.3350/cmh.2021.0148

View: 7017 Download: 327 Web of Science: 11 Crossref: 13

Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2016;22(2):286-291. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2015.0066

View: 10663 Download: 175 Web of Science: 11 Crossref: 13

Yun Jung Choi, Jeong Han Kim, Ja Kyung Koo, Cho I Lee, Ji Young Lee, Jae Hoon Yang, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2014;20(2):185-191. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.185

View: 9685 Download: 117 Web of Science: 32 Crossref: 27

Jihyun An, Joo Ho Lee, Hyojeong Lee, Eunsil Yu, Dan Bi Lee, Ju Hyun Shim, Sunyoung Yoon, Yumi Lee, Soeun Park, Han Chu Lee

Clin Mol Hepatol. 2012;18(1):84-88. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.84

View: 7168 Download: 56 Crossref: 8

Mi Yeon Chung, Dae Won Jun, Su Ah Sung

Clin Mol Hepatol. 2010;16(3):301-307. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.301

View: 10050 Download: 77 Crossref: 19

1 |

Viewed By 5996	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5515	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 5296	MAFLD: How is it different from NAFLD?
Viewed By 5273	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4856	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 208	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 146	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 119	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 109	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search